Additional File 1.

Figure S1 - Different NMDAR antagonists are able to reduce the (NRG1+NMDA)-induced migration. ErbB4-transfected ST14A cells were treated with 8 μM NMDA + 5 nM NRG1 for 18 hrs (control condition) in the presence of various NMDA receptor antagonists: PPDA (0.5 μM), UBP141 (5 μM), MK801 (10 μM) and D-AP5 (30 μM). Migration was calculated as percentage of total migrated cells as described in Material and Methods. Data are presented as means + SD (n = 3). Statistical analysis was performed by one-way ANOVA followed by Tuckey's test, *** = p < 0.001, ** = p < 0.01, * = p < 0.05.

Format: PDF Size: 802KB Download file

This file can be viewed with: Adobe Acrobat Reader

Pregno et al. BMC Neuroscience 2011 12:103   doi:10.1186/1471-2202-12-103